UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Piroxicam-β-cyclodextrin: a GI safer piroxicam

Current medicinal chemistry, 2013-06, Vol.20 (19), p.2415-2437

Scarpignato, C

2013

Volltextzugriff (PDF)

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

BMJ (Online), 2013-08, Vol.347 (aug07 1), p.f4587-f4587

International edition, 2013

Volltextzugriff (PDF)

Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth

Alimentary pharmacology & therapeutics, 2017-03, Vol.45 (5), p.604-616

2017

Volltextzugriff (PDF)

Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end

Neurogastroenterology and motility, 2012-08, Vol.24 (8), p.697-704

Scarpignato, C.

2012

Volltextzugriff (PDF)

Commentary: towards a cardiac safe prokinetic

Alimentary pharmacology & therapeutics, 2012-05, Vol.35 (10), p.1243-1244

Scarpignato, C.

2012

Volltextzugriff (PDF)

Letter: can the overall gastrointestinal safety of celecoxib be extended to all COX‐2‐selective agents?

Alimentary pharmacology & therapeutics, 2018-07, Vol.48 (1), p.108-110

2018

Volltextzugriff (PDF)

The burden of constipation on quality of life: results of a multinational survey

Alimentary pharmacology & therapeutics, 2007-07, Vol.26 (2), p.227-236

2007

Volltextzugriff (PDF)

Editorial: Helicobacter pylori resistance and sequential therapy—authors’ reply

Alimentary pharmacology & therapeutics, 2018-07, Vol.48 (1), p.96-97

2018

Volltextzugriff (PDF)

NSAID-induced intestinal damage: are luminal bacteria the therapeutic target?

Gut, 2008-02, Vol.57 (2), p.145-148

Scarpignato, C

2008

Volltextzugriff (PDF)

Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5‐year study on a large number of strains

Alimentary pharmacology & therapeutics, 2018-05, Vol.47 (9), p.1261-1269

2018

Volltextzugriff (PDF)

Editorial: towards extended acid suppression – the search continues

Alimentary pharmacology & therapeutics, 2015-10, Vol.42 (8), p.1027-1029

2015

Volltextzugriff (PDF)

Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation

Alimentary pharmacology & therapeutics, 2017-03, Vol.45 (5), p.631-642

2017

Volltextzugriff (PDF)

Commentary: towards an effective and safe treatment of small intestine bacterial overgrowth

Alimentary pharmacology & therapeutics, 2013-12, Vol.38 (11-12), p.1409-1410

2013

Volltextzugriff (PDF)

Editorial: hyponatremia – a possible but forgotten consequence of bowel preparation for colonoscopy

Alimentary pharmacology & therapeutics, 2014-11, Vol.40 (9), p.1110-1112

2014

Volltextzugriff (PDF)

Editorial: adequate management may reduce the colorectal cancer risk associated with constipation

Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (5), p.562-564

2014

Volltextzugriff (PDF)

A multinational survey of prevalence and patterns of laxative use among adults with self‐defined constipation

Alimentary pharmacology & therapeutics, 2008-10, Vol.28 (7), p.917-930

2008

Volltextzugriff (PDF)

Proton pump inhibitors: the beginning of the end or the end of the beginning?

Current opinion in pharmacology, 2008-12, Vol.8 (6), p.677-684

2008

Volltextzugriff (PDF)

Management of perforated diverticulitis with generalized peritonitis. A multidisciplinary review and position paper

Techniques in coloproctology, 2021-02, Vol.25 (2), p.153-165

2021

Volltextzugriff (PDF)

Determinants of the short‐term gastric damage caused by NSAIDs in man

Alimentary pharmacology & therapeutics, 2007-07, Vol.26 (1), p.95-106

2007

Volltextzugriff (PDF)

Editorial: healing of refractory reflux oesophagitis – an ongoing unmet clinical need

Alimentary pharmacology & therapeutics, 2014-10, Vol.40 (8), p.987-989

2014

Volltextzugriff (PDF)

Experimental and Clinical Pharmacology of Rifaximin, a Gastrointestinal Selective Antibiotic

Digestion, 2006-01, Vol.73 (Suppl 1), p.13-27

2006

Volltextzugriff (PDF)

Role of the A2B receptor–adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats

British journal of pharmacology, 2014-03, Vol.171 (5), p.1314-1329

2014

Volltextzugriff (PDF)

Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats

British journal of pharmacology, 2014-03, Vol.171 (5), p.1314

2014

Volltextzugriff (PDF)

P.04.7: Ethinylestradiol/Levonorgestrel Oral Contraceptive and Acute Pancreatitis: A Case Series

Digestive and liver disease, 2017-03, Vol.49, p.e155-e156

2017

Volltextzugriff (PDF)

P.18.7 DOSE- AND TIME-DEPENDENT ERADICATION OF SMALL INTESTINE BACTERIAL OVERGROWTH (SIBO) WITH RIFAXIMIN: A META-ANALYTIC APPROACH

Digestive and liver disease, 2014-03, Vol.46, p.S129-S129

2014

Volltextzugriff (PDF)

1 – 25 von 338

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(245)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Piroxicam-β-cyclodextrin: a GI safer piroxicam

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth

Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end

Commentary: towards a cardiac safe prokinetic

Letter: can the overall gastrointestinal safety of celecoxib be extended to all COX‐2‐selective agents?

The burden of constipation on quality of life: results of a multinational survey

Editorial: Helicobacter pylori resistance and sequential therapy—authors’ reply

NSAID-induced intestinal damage: are luminal bacteria the therapeutic target?

Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5‐year study on a large number of strains

Editorial: towards extended acid suppression – the search continues

Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation

Commentary: towards an effective and safe treatment of small intestine bacterial overgrowth

Editorial: hyponatremia – a possible but forgotten consequence of bowel preparation for colonoscopy

Editorial: adequate management may reduce the colorectal cancer risk associated with constipation

A multinational survey of prevalence and patterns of laxative use among adults with self‐defined constipation

Proton pump inhibitors: the beginning of the end or the end of the beginning?

Management of perforated diverticulitis with generalized peritonitis. A multidisciplinary review and position paper

Determinants of the short‐term gastric damage caused by NSAIDs in man

Editorial: healing of refractory reflux oesophagitis – an ongoing unmet clinical need

Experimental and Clinical Pharmacology of Rifaximin, a Gastrointestinal Selective Antibiotic

Role of the A2B receptor–adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats

Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats

P.04.7: Ethinylestradiol/Levonorgestrel Oral Contraceptive and Acute Pancreatitis: A Case Series

P.18.7 DOSE- AND TIME-DEPENDENT ERADICATION OF SMALL INTESTINE BACTERIAL OVERGROWTH (SIBO) WITH RIFAXIMIN: A META-ANALYTIC APPROACH

Suchergebnisse filtern